Report Thumbnail
Product Code IM0913612468A3
Published Date 2023/5/29
English142 PagesGlobal

Smart Medical Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028MedicalDevice_MedTech Market


Report Thumbnail
Product Code IM0913612468A3◆The May 2026 edition is also likely available. We will check with the publisher immediately.
Published Date 2023/5/29
English 142 PagesGlobal

Smart Medical Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028MedicalDevice_MedTech Market



Abstract


Summary

The global smart medical devices market size reached US$ 40.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 62.8 Billion by 2028, exhibiting a growth rate (CAGR) of 7.39% during 2023-2028. Smart medical devices are wireless electronic instruments intended to monitor patients' health by collecting and communicating real-time updates. Insulin pumps, heart rate monitors, pulse oximeters, portable oxygen concentrators and blood pressure monitors are some of the commonly used smart medical devices. These devices are usually operated on a wireless network like wi-fi, Bluetooth, and various technologies and are widely used to monitor, analyze and transmit patient’s critical data. Smart medical devices provide a high level of mobility, ability to monitor patient status remotely. They also assist in reducing workload, saving time, increasing patient engagement and control, reducing errors, improving communication, and enhancing safety. As a result, smart medical devices are widely used in hospitals, clinics and home care settings. Smart Medical Devices Market Trends: Significant growth in the healthcare industry across the globe is one of the key factors creating a positive outlook of the market. The increasing prevalence of chronic medical ailments, such as asthma, diabetes, blood pressure and chronic obstructive pulmonary disease (COPD), has facilitated the usage of these devices across various healthcare settings. Additionally, the widespread adoption of smart wearable medical devices due to the rising health consciousness among the masses is favoring the market growth. Moreover, various technological advancements, such as the integration of artificial intelligence (AI), Internet of Things (IoT) and machine-to-machine technology, are providing a thrust to market growth. These technologies offer greater precision, ensure accurate storing and monitoring of patient information, and enhance the overall user experience. In line with this, the increasing product demand in home care settings due to the sudden outbreak of coronavirus disease (COVID-19) for disease management, monitoring, providing feedback and suggesting adequate treatment is positively impacting the market growth. Other factors, including rising expenditure capacity of consumers, rising geriatric population, along with the implementation of various government initiatives to spread awareness about disease prevention, are anticipated to drive the market toward growth. Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global smart medical devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, distribution channel, application and end user. Breakup by Product Type: Diagnostic and Monitoring Blood Glucose Monitors Heart Rate Monitors Pulse Oximeters Blood Pressure Monitors Breath Analyzer Other Diagnostic Monitoring Products Therapeutic Devices Portable Oxygen Concentrators and Ventilators Insulin Pumps Hearing Aid Other Therapeutic Devices Breakup by Distribution Channel: Pharmacies Online Others Breakup by Application: Oncology Diabetes Auto-Immune Disorders Infectious Diseases Others Breakup by End User: Hospitals and Clinics Home-Care Setting Others Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Activinsights Ltd, Apple Inc., Debiotech SA, Enable Injections, Fitbit LLC (Google LLC), Koninklijke Philips N.V., Medtronic PLC, NeuroMetrix Inc., Omron Healthcare Co Ltd (Omron Corporation), Sonova Holding AG, Sotera Wireless Inc. and VitalConnect. Key Questions Answered in This Report 1. What was the size of the global smart medical devices market in 2022? 2. What is the expected growth rate of the global smart medical devices market during 2023-2028? 3. What are the key factors driving the global smart medical devices market? 4. What has been the impact of COVID-19 on the global smart medical devices market? 5. What is the breakup of the global smart medical devices market based on the product type? 6. What is the breakup of the global smart medical devices market based on the distribution channel? 7. What are the key regions in the global smart medical devices market? 8. Who are the key players/companies in the global smart medical devices market?

Table of Contents

  • 1 Preface

  • 2 Scope and Methodology

    • 2.1 Objectives of the Study
    • 2.2 Stakeholders
    • 2.3 Data Sources
      • 2.3.1 Primary Sources
      • 2.3.2 Secondary Sources
    • 2.4 Market Estimation
      • 2.4.1 Bottom-Up Approach
      • 2.4.2 Top-Down Approach
    • 2.5 Forecasting Methodology
  • 3 Executive Summary

  • 4 Introduction

    • 4.1 Overview
    • 4.2 Key Industry Trends
  • 5 Global Smart Medical Devices Market

    • 5.1 Market Overview
    • 5.2 Market Performance
    • 5.3 Impact of COVID-19
    • 5.4 Market Forecast
  • 6 Market Breakup by Product Type

    • 6.1 Diagnostic and Monitoring
      • 6.1.1 Market Trends
      • 6.1.2 Key Segments
        • 6.1.2.1 Blood Glucose Monitors
        • 6.1.2.2 Heart Rate Monitors
        • 6.1.2.3 Pulse Oximeters
        • 6.1.2.4 Blood Pressure Monitors
        • 6.1.2.5 Breath Analyzer
        • 6.1.2.6 Other Diagnostic Monitoring Products
      • 6.1.3 Market Forecast
    • 6.2 Therapeutic Devices
      • 6.2.1 Market Trends
      • 6.2.2 Key Segments
        • 6.2.2.1 Portable Oxygen Concentrators and Ventilators
        • 6.2.2.2 Insulin Pumps
        • 6.2.2.3 Hearing Aid
        • 6.2.2.4 Other Therapeutic Devices
      • 6.2.3 Market Forecast
  • 7 Market Breakup by Distribution Channel

    • 7.1 Pharmacies
      • 7.1.1 Market Trends
      • 7.1.2 Market Forecast
    • 7.2 Online
      • 7.2.1 Market Trends
      • 7.2.2 Market Forecast
    • 7.3 Others
      • 7.3.1 Market Trends
      • 7.3.2 Market Forecast
  • 8 Market Breakup by Application

    • 8.1 Oncology
      • 8.1.1 Market Trends
      • 8.1.2 Market Forecast
    • 8.2 Diabetes
      • 8.2.1 Market Trends
      • 8.2.2 Market Forecast
    • 8.3 Auto-Immune Disorders
      • 8.3.1 Market Trends
      • 8.3.2 Market Forecast
    • 8.4 Infectious Diseases
      • 8.4.1 Market Trends
      • 8.4.2 Market Forecast
    • 8.5 Others
      • 8.5.1 Market Trends
      • 8.5.2 Market Forecast
  • 9 Market Breakup by End User

    • 9.1 Hospitals and Clinics
      • 9.1.1 Market Trends
      • 9.1.2 Market Forecast
    • 9.2 Home-Care Setting
      • 9.2.1 Market Trends
      • 9.2.2 Market Forecast
    • 9.3 Others
      • 9.3.1 Market Trends
      • 9.3.2 Market Forecast
  • 10 Market Breakup by Region

    • 10.1 North America
      • 10.1.1 United States
        • 10.1.1.1 Market Trends
        • 10.1.1.2 Market Forecast
      • 10.1.2 Canada
        • 10.1.2.1 Market Trends
        • 10.1.2.2 Market Forecast
    • 10.2 Asia-Pacific
      • 10.2.1 China
        • 10.2.1.1 Market Trends
        • 10.2.1.2 Market Forecast
      • 10.2.2 Japan
        • 10.2.2.1 Market Trends
        • 10.2.2.2 Market Forecast
      • 10.2.3 India
        • 10.2.3.1 Market Trends
        • 10.2.3.2 Market Forecast
      • 10.2.4 South Korea
        • 10.2.4.1 Market Trends
        • 10.2.4.2 Market Forecast
      • 10.2.5 Australia
        • 10.2.5.1 Market Trends
        • 10.2.5.2 Market Forecast
      • 10.2.6 Indonesia
        • 10.2.6.1 Market Trends
        • 10.2.6.2 Market Forecast
      • 10.2.7 Others
        • 10.2.7.1 Market Trends
        • 10.2.7.2 Market Forecast
    • 10.3 Europe
      • 10.3.1 Germany
        • 10.3.1.1 Market Trends
        • 10.3.1.2 Market Forecast
      • 10.3.2 France
        • 10.3.2.1 Market Trends
        • 10.3.2.2 Market Forecast
      • 10.3.3 United Kingdom
        • 10.3.3.1 Market Trends
        • 10.3.3.2 Market Forecast
      • 10.3.4 Italy
        • 10.3.4.1 Market Trends
        • 10.3.4.2 Market Forecast
      • 10.3.5 Spain
        • 10.3.5.1 Market Trends
        • 10.3.5.2 Market Forecast
      • 10.3.6 Russia
        • 10.3.6.1 Market Trends
        • 10.3.6.2 Market Forecast
      • 10.3.7 Others
        • 10.3.7.1 Market Trends
        • 10.3.7.2 Market Forecast
    • 10.4 Latin America
      • 10.4.1 Brazil
        • 10.4.1.1 Market Trends
        • 10.4.1.2 Market Forecast
      • 10.4.2 Mexico
        • 10.4.2.1 Market Trends
        • 10.4.2.2 Market Forecast
      • 10.4.3 Others
        • 10.4.3.1 Market Trends
        • 10.4.3.2 Market Forecast
    • 10.5 Middle East and Africa
      • 10.5.1 Market Trends
      • 10.5.2 Market Breakup by Country
      • 10.5.3 Market Forecast
  • 11 SWOT Analysis

    • 11.1 Overview
    • 11.2 Strengths
    • 11.3 Weaknesses
    • 11.4 Opportunities
    • 11.5 Threats
  • 12 Value Chain Analysis

  • 13 Porters Five Forces Analysis

    • 13.1 Overview
    • 13.2 Bargaining Power of Buyers
    • 13.3 Bargaining Power of Suppliers
    • 13.4 Degree of Competition
    • 13.5 Threat of New Entrants
    • 13.6 Threat of Substitutes
  • 14 Price Analysis

  • 15 Competitive Landscape

    • 15.1 Market Structure
    • 15.2 Key Players
    • 15.3 Profiles of Key Players
      • 15.3.1 Abbott Laboratories
        • 15.3.1.1 Company Overview
        • 15.3.1.2 Product Portfolio
        • 15.3.1.3 Financials
        • 15.3.1.4 SWOT Analysis
      • 15.3.2 Activinsights Ltd
        • 15.3.2.1 Company Overview
        • 15.3.2.2 Product Portfolio
      • 15.3.3 Apple Inc
        • 15.3.3.1 Company Overview
        • 15.3.3.2 Product Portfolio
        • 15.3.3.3 Financials
        • 15.3.3.4 SWOT Analysis
      • 15.3.4 Debiotech SA
        • 15.3.4.1 Company Overview
        • 15.3.4.2 Product Portfolio
      • 15.3.5 Enable Injections
        • 15.3.5.1 Company Overview
        • 15.3.5.2 Product Portfolio
      • 15.3.6 Fitbit LLC (Google LLC)
        • 15.3.6.1 Company Overview
        • 15.3.6.2 Product Portfolio
      • 15.3.7 Koninklijke Philips N.V
        • 15.3.7.1 Company Overview
        • 15.3.7.2 Product Portfolio
        • 15.3.7.3 Financials
        • 15.3.7.4 SWOT Analysis
      • 15.3.8 Medtronic PLC
        • 15.3.8.1 Company Overview
        • 15.3.8.2 Product Portfolio
        • 15.3.8.3 Financials
        • 15.3.8.4 SWOT Analysis
      • 15.3.9 NeuroMetrix Inc
        • 15.3.9.1 Company Overview
        • 15.3.9.2 Product Portfolio
        • 15.3.9.3 Financials
      • 15.3.10 Omron Healthcare Co Ltd (Omron Corporation)
        • 15.3.10.1 Company Overview
        • 15.3.10.2 Product Portfolio
        • 15.3.10.3 SWOT Analysis
      • 15.3.11 Sonova Holding AG
        • 15.3.11.1 Company Overview
        • 15.3.11.2 Product Portfolio
      • 15.3.12 Sotera Wireless Inc
        • 15.3.12.1 Company Overview
        • 15.3.12.2 Product Portfolio
      • 15.3.13 VitalConnect
        • 15.3.13.1 Company Overview
        • 15.3.13.2 Product Portfolio
USD 3,999 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.